Copyright © Inderes 2011 - present. All rights reserved.
Log in
Search
Latest
Markets
Morning Review
Stock Comparison
Financial Calendar
Dividends Calendar
Research
Articles
Transcripts
AGM Invitations
IPOs
inderesTV
Portfolio
Forum
Discovery
Q&A
About Us
Our Coverage
Team
Collapse
Language
Regulatory press release
Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders
0 likes
0 dislikes
Novonesis
Please read the announcement in PDF
Attachment
2023_50_Combination_between_Novozymes_and_Chr._Hansen_approved_by_the_Novozymes_shareholders
Inderes’ Disclaimer can be found
here
. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.